期刊文献+

β-紫罗兰酮温敏脂质体的制备工艺及配方优化 被引量:5

Optimization of Preparation and Formula for Beta-Ionone Liposome
下载PDF
导出
摘要 以合成磷脂DPPC和氢化大豆卵磷脂HSPC为膜材,采用薄膜超声法和乙醇注入法制备β-紫罗兰酮脂质体,并对其超声条件及配方进行优化。优化得到的较佳工艺参数为:超声功率240 W,超声时间4 min。通过单因素实验优化得到的β-紫罗兰酮脂质体的较佳配方为:DPPC与HSPC摩尔比为8∶2,磷脂质量浓度10 mg/m L,β-紫罗兰酮与Tween80、磷脂的质量比为1∶1∶20。该条件下制备的脂质体包封率为(60.62±3.48)%,平均粒径在200 nm左右,在原子力显微镜的观察下为球状或近似球状的小囊泡。 To prepare beta-ionone liposomes bythin-film evaporation and ethanol injection using DPPC (1,2-dipalmitoyl-sn-glycero-3-phosphocholine) and HSPC (hydrogenated soy phosphatidy- lcholine) as membrane materials, as well as optimize its preparation formula.The results showed that the optimal preparation condition and formula of beta-ionone liposomes was as follows :the molar ratio of DPPC to HSPCwas 8:2,the concentration of phosphatidylcholine (PC)was 10 mg/mL,the mass ratio of beta ionone toPCs was 1:20, the ratio of Tween80 to PCs was 1:20, the ultrasonic power was 240 W,the time was 4 min.Under these conditions,entrapment efficiency of beta-ionone liposomes was 60.62%+3.48%. The diameters of beta-ionone liposomes were about 200nm,the appearances ofbeta-ionone liposomes were completely or approximately globular vesicles under atomic force microscope (AFM).
出处 《食品与生物技术学报》 CAS CSCD 北大核心 2017年第10期1022-1028,共7页 Journal of Food Science and Biotechnology
基金 国家自然科学基金项目(31171686) 烟草化学安徽省重点实验室2013年开放课题资助项目(0920140109010)
关键词 Β-紫罗兰酮 脂质体 二棕榈酰磷脂酰胆碱DPPC 氢化大豆卵磷脂HSPC beta-ionone,liposomes,DPPC(1,2-dipalmitoyl-sn-glycero-3-phosphocholine) ,HSPC (hydrogenated soy phosphatidylcholin )
  • 相关文献

参考文献3

二级参考文献26

  • 1张雪娇,程永清,李丽君,王小荣.包膜微泡超声造影剂的研究进展[J].中国医学影像技术,2005,21(5):819-821. 被引量:17
  • 2罗支农,黄晓川,陈薏兰,陈德钊,林琼,郑燕烈,张连云,宾建平,孟林,张榕华,刘伊丽,秦建新.静注声振微气泡左心声学造影的实验研究[J].中国超声医学杂志,1995,11(5):378-379. 被引量:2
  • 3YA-JEN CHANG, CHIH-HSIEN Therapeutic efficacy and CHANG, CHIA-YU YU, et al. microSPECT/CT imaging of 188Re-DXR-liposome in a C26 routine colon carcinoma solid tumor modal [J]. Nuclear Medicine and Biology, 2010, 37(1): 95-104.
  • 4PAUL DE VOS, MARIJKE M FAAS, MILICA SPASOJEVIC, et al. Encapsulation for preservation of functionality and targeted delivery of bioactive food components[J]. International Dairy Jour- nal, 2010, 20(4): 292-302.
  • 5PILCER G, AMIGHI K. Formulation strategy and use of excipi- ents in pulmonary drug delivery[J]. International Journal of Phar- maceutics, 2010, 392(1-2): 1-19.
  • 6HIROSHI UMAKOSHI, KEISHI SUGA, HUONG THI BUI, et al. Charged liposome affects the translation and folding steps of in vitro expression of green fluorescent protein [J]. J Biosci Bioeng, 2009, 108(5): 450-454.
  • 7SOUNDARARA.IAN A, BAO A, PHILLIPS WT, et al. [186Re] Liposomal doxorubicin (Doxil): in vitro stability, pharmacokinetics, imaging and biodistribution in a head and neck squamous cell carcinoma xenograft modal [J]. Nuclear Medicine and Biology, 2009, 36(5): 515-524.
  • 8BETZ al. In metic 296(1 G, AEPPLI A MENSHUTINA N LEUENBERGER H, et vivo comparison of vm'ious liposome formulations for cos- application[J]. International Journal of Pharmaceutics, 2005, -2): 44-54.
  • 9DA SILVA MALHEIROS P, DAROIT D J, BRANDELLI A. Food applications of liposome-encapsulated antimicrobial peptides [J]. Trends in Food Science & Technology, In Press, Corrected Proof.
  • 10SCHROEDER A, KOST J, BARENHOLZ Y. Ultrasound, lipo- somes, and drug delivery: principles for using ultrasound to con- trol the release of drugs from liposomes [J]. Chemistry and Physics of Lipids, 2009, 162(1-2): 1-16.

共引文献13

同被引文献90

引证文献5

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部